Bioburden
Sample results, hold times, transfer events, and microbial trends are aligned with process context.
Home / Platform / Contamination intelligence
Contamination and deviation agentBioseon fuses bioburden, environmental monitoring, and process signals into a live contamination and deviation picture for biologics manufacturing.
Bioburden, EM, pH, DO, pressure, spectroscopy anomalies, operator interventions, and suite events are evaluated together.
A single contamination or viral event can destroy a biologics batch worth millions and idle a suite for weeks.
Product, media, consumables, resin, labor, and lost slot value disappear quickly.
Investigation, cleaning, testing, and restart can freeze capacity.
GMP deviation handling must prove what happened, when, and why.
Sample results, hold times, transfer events, and microbial trends are aligned with process context.
Viable and non-viable particles, room status, personnel flows, and EM excursions become part of the batch state.
pH, DO, pressure, gas, feed, temperature, spectroscopy, and skid behavior expose abnormal patterns.
Most single signals are ambiguous. Bioseon looks for timing, correlation, and process phase: a subtle pH drift, unexpected oxygen demand, EM event, or spectroscopy change can mean more when viewed with the full batch record.
Alerts include signal sources, contributing events, phase, impacted unit operation, and recommended review path.
Bioseon helps classify events, connect impacted CPPs and CQAs, and prepare review-by-exception evidence for QA.
The contamination-and-deviation agent links the live risk picture to batch records, operator actions, equipment state, and relevant GMP controls so teams can decide faster and document clearly.
Fuse bioburden, environmental monitoring, and process signals into a live risk score and evidence packet.
Identify impacted vessel, skid, suite, transfer, material, lot, or operator pathway.
Estimate product impact, CQA risk, and whether the batch can remain inside the validated strategy.
Recommend holds, sampling, segregation, cleaning, or escalation within site procedures.
Assemble timestamps, signals, actions, and rationale for Part 11 review.
Bring weak signals into one contamination picture.
Prioritize deviations by impact to product and process state.
Package evidence for QA while context is still fresh.
Reduce avoidable suite downtime and investigation drag.
Bioseon aligns with GMP, 21 CFR Part 11, and ICH Q8-Q11 quality-by-design. It connects contamination evidence to records, signatures, and review-by-exception workflows.
Every signal, alert, containment action, reviewer note, and e-signature is preserved with provenance.
Line is $13,000/skid/mo, Site is $85,000/mo, and Enterprise is custom for multi-site and validation programs.
No. Bioseon presents live evidence, risk, and documentation. Qualified site personnel retain release and disposition authority.
Deployments commonly include bioburden, environmental monitoring, process historian, PAT or spectroscopy, batch records, and equipment events.
It detects weak signal combinations earlier, routes response playbooks, and preserves the evidence needed for clean deviation handling.
Request access and scope Bioseon against your suite, EM program, bioburden data, and batch-record workflows.